Ameridose in Mass. to remain closed through year
BOSTON (AP) — A Massachusetts drug company with the same founders as a compounding pharmacy tied to a deadly meningitis outbreak has agreed with state regulators to remain closed through the year.
Ameridose first agreed to close for inspection in October after tainted steroids from its sister company, the New England Compounding Center, were linked to a fungal meningitis outbreak that caused 32 deaths. The agreement has been extended several times. The latest would have expired Monday.
Ameridose has laid off most workers and recalled its products, though none has been found contaminated. The company makes injectable drugs for hospitals.
The U.S. Food and Drug Administration said Monday that its monthlong inspection of Ameridose found potential sources of contamination, including leaky ceilings and insects. Ameridose has said it'll work to address those issues.
Business Photo Galleriesview all
- 101218Oklahoma tornadoes: The 'Big Dog,' the little boy and the hug that triumphs over tragedy
- 15357OKC Thunder: Kevin Durant tours Moore, meets with residents
- 13402Oklahoma tornadoes: ‘All I could do was sit there and hold her'
- 8724Line of storms brings flash floods to Oklahoma City area
- 8110How to help tornado victims
- 8098Oklahoma tornadoes: Love for Oklahoma generates big donation
- 8041Oklahoma tornadoes: Rams quarterback Sam Bradford leading aid effort